-
1
-
-
0029100429
-
2A receptor gene
-
2A receptor gene. Lancet 1995; 346:281-282
-
(1995)
Lancet
, vol.346
, pp. 281-282
-
-
Arranz, M.1
Collier, D.2
Sodhi, M.3
Ball, D.4
Roberts, G.5
Price, J.6
Sham, P.7
Kerwin, R.8
-
3
-
-
0021646446
-
2 involvement in the mechanism of action of hallucinogenic agents
-
2 involvement in the mechanism of action of hallucinogenic agents. Life Sci 1984; 35:2505-2511
-
(1984)
Life Sci
, vol.35
, pp. 2505-2511
-
-
Glennon, R.A.1
Titeler, M.2
McKenney, J.D.3
-
4
-
-
0028114486
-
An overview of the mechanism of action of clozapine
-
Meltzer HY: An overview of the mechanism of action of clozapine. J Clin Psychiatry 1994; 55 (Sept suppl B):47-52
-
(1994)
J Clin Psychiatry
, vol.55
, Issue.SEPT SUPPL. B
, pp. 47-52
-
-
Meltzer, H.Y.1
-
5
-
-
0029151653
-
Genetic variation of the 5-HT2A receptor and response to clozapine
-
Nothen MM, Rietschel M, Erdmann J, Oberlander H, Moller HJ, Naber D, Propping P: Genetic variation of the 5-HT2A receptor and response to clozapine. Lancet 1995; 346:908-909
-
(1995)
Lancet
, vol.346
, pp. 908-909
-
-
Nothen, M.M.1
Rietschel, M.2
Erdmann, J.3
Oberlander, H.4
Moller, H.J.5
Naber, D.6
Propping, P.7
-
7
-
-
0029654769
-
2A receptor and response to clozapine
-
2A receptor and response to clozapine (letter). Lancet 1995; 346:909
-
(1995)
Lancet
, vol.346
, pp. 909
-
-
Burnet, P.W.1
Harrison, P.J.2
-
9
-
-
0025223081
-
Turning off the signal: Desensitization of beta-adrenergic receptor function
-
Hausdorff WP, Caron MG, Lefkowitz RJ: Turning off the signal: desensitization of beta-adrenergic receptor function. FASEB J 1990; 4:2881-2889
-
(1990)
FASEB J
, vol.4
, pp. 2881-2889
-
-
Hausdorff, W.P.1
Caron, M.G.2
Lefkowitz, R.J.3
-
10
-
-
0028913523
-
An E-M algorithm and testing strategy for multiple-locus haplotypes
-
Long JC, Williams RC, Urbanek M: An E-M algorithm and testing strategy for multiple-locus haplotypes. Am J Hum Genet 1995; 56:799-810
-
(1995)
Am J Hum Genet
, vol.56
, pp. 799-810
-
-
Long, J.C.1
Williams, R.C.2
Urbanek, M.3
-
11
-
-
0026772116
-
Clinical and biologic response to clozapine in patients with schizophrenia: Crossover comparison with fluphenazine
-
Pickar D, Owen RR, Litman RE, Konicki E, Gutierrez R, Rapaport MH: Clinical and biologic response to clozapine in patients with schizophrenia: crossover comparison with fluphenazine. Arch Gen Psychiatry 1992; 49:345-353
-
(1992)
Arch Gen Psychiatry
, vol.49
, pp. 345-353
-
-
Pickar, D.1
Owen, R.R.2
Litman, R.E.3
Konicki, E.4
Gutierrez, R.5
Rapaport, M.H.6
-
12
-
-
0023812652
-
Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine
-
Kane J, Honigfeld G, Singer J, Meltzer H: Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988; 45:789-796
-
(1988)
Arch Gen Psychiatry
, vol.45
, pp. 789-796
-
-
Kane, J.1
Honigfeld, G.2
Singer, J.3
Meltzer, H.4
-
13
-
-
0028172045
-
Allelic variation in the D4 dopamine receptor (DRD4) gene does not predict response to clozapine
-
Rao PA, Pickar D, Gejman PC, Ram A, Gershon ES, Gelernter J: Allelic variation in the D4 dopamine receptor (DRD4) gene does not predict response to clozapine. Arch Gen Psychiatry 1994; 51:912-917
-
(1994)
Arch Gen Psychiatry
, vol.51
, pp. 912-917
-
-
Rao, P.A.1
Pickar, D.2
Gejman, P.C.3
Ram, A.4
Gershon, E.S.5
Gelernter, J.6
|